This inventor holds 1 USPTO granted patent. Top assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., University of South Florida. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2012
Title: Qing Chen - Innovator in Oncological Treatments
Introduction
Qing Chen is a notable inventor based in Tampa, FL, who has made significant contributions to the field of oncology. His work focuses on developing innovative materials and methods for treating oncological disorders, aiming to improve patient outcomes in cancer therapy.
Latest Patents
Qing Chen holds a patent for "Materials and methods for treating oncological disorders." This invention addresses the challenges of cancer treatment, particularly in preventing or reducing the development of resistance to anticancer therapies such as chemotherapy, radiotherapy, and immunotherapy. The patent outlines various embodiments, including the use of agents that inhibit cholesterol synthesis in therapy-resistant cancer cells and those that enhance the expression of Bim protein in cells. Additionally, it discusses methods to inhibit cancer cell adhesion and the DNA crosslink repair function of cells.
Career Highlights
Throughout his career, Qing Chen has worked with esteemed institutions, including the H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida. His research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Qing Chen has collaborated with notable colleagues such as William S. Dalton and Lori Hazlehurst, who have contributed to his research endeavors in the field of oncology.
Conclusion
Qing Chen's innovative work in developing treatments for oncological disorders showcases his commitment to improving cancer therapies. His contributions are vital in the ongoing battle against cancer, and his patent reflects a significant step forward in this critical area of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile